Login to Your Account

Chiesi Pulls Trigger on Cornerstone Purchase

By Marie Powers
Staff Writer

Wednesday, September 18, 2013
Cornerstone Therapeutics Inc.’s largest shareholder, Italian pharma Chiesi Farmaceutici SpA, sweetened its original bid to purchase the specialty pharma’s remaining shares, settling on $9.50 each in cash.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription